Vanda Pharmaceuticals reported $56K in Ordinary Share Capital for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US $ 0.02M 0M
Agios Pharmaceuticals AGIO:US $ 0.07M 0M
Akebia Therapeutics AKBA:US $ 0M 0M
Alnylam Pharmaceuticals ALNY:US $ 1.2M 0.01M
Anika Therapeutics ANIK:US $ 0.14M 0M
Arena Pharmaceuticals ARNA:US $ 0.01M 0M
AstraZeneca AZN:LN 387M 59M
Bluebird Bio BLUE:US $ 0.7M 0.02M
Bristol Myers Squibb BMY:US $ 292M 0M
Clovis Oncology CLVS:US $ 0.13M 0.01M
Eli Lilly And LLY:US $ 598.2M 0.1M
Esperion Therapeutics ESPR:US $ 27K 1000
Halozyme Therapeutics HALO:US $ 0.14M 0M
Heron Therapeutics HRTX:US $ 1.02M 0M
Insmed INSM:US $ 1.18M 32K
Ligand Pharmaceuticals LGND:US $ 0.02M 0M
Minerva Neurosciences NERV:US $ 0M 0M
Moderna Inc MRNA:US 40.5K 40.5K
Novartis NVS:US $ 901M 12M
Ptc Therapeutics PTCT:US $ 0.07M 0M
Puma Biotechnology PBYI:US $ 0M 0M
Sangamo Biosciences SGMO:US $ 1.46M 0M
Takeda 4502:JP Y 1676263M 7138M
Teva Pharmaceutical TEVA:IT 57M 0
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M
Vanda Pharmaceuticals VNDA:US $ 0.06M 0M
Veracyte VCYT:US $ 0.07M 0M